Ms. Deepa. K. Nair, Dr. B. Shanthi. MD, Dr.Supriya Simon A Msc Ph.D, Dr. V. S. Kalai Selvi MD


Diabetes mellitus (DM) is a group of metabolic diseases which if not controlled can cause life threatening complication. The objective of the study
is to assess the correlation of urine microalbumin (MAU) with (HbA1C) in type 2 DM patients. Total 180 patients diagnosed for type 2 DM, age
30-60 years were selected and fasting plasma glucose, creatinine,HbA1C and MAU were estimated.HbA1C levels and MAU levels shows
significant positive correlation (r = 0.429, p<0.01) and the relationship is significant for all the three age groups. The study concluded that there was
an increased prevalence of MAU and high HbA1C level among the patients with type 2 DM, and also highlights that there is a significant correlation
between MAU levels and HbA1C for all the three age groups which necessitates for early detection of nephropathy and uncontrolled diabetes.


Dinneen SF and Pizza RA: Classification and diagnosis of diabetes mellitus. In: De grot L, Jameson JL, editors. Endocrinology, Volume 1, 4th ed. Philadelphia: WB Saunders Company 2001: 756.

Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes 2009; 1(1):18 28.

American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2011; 34(Suppl 1):62-69.

Power AC: Diabetes Mellitus. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principles of Internal Medicine.15th ed. New York. The McGraw-Hill Companies Inc 2001; 2: 2109

Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med.2002; 19:527–534. Doi: 10.1046/j.1464-5491.2002.00745.x.

International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 9th edition, 3. 2019, http://www.diabetesatlas.org

Reasons For Elevated A1C Without Diabetes by Robert Rister — 2017-07-19;Lymphatic & Endocrine system; SteadyHealth.com

Guglielmi MD, Pierdomenico SD, Salvatore L, et al. Impaired LV diastolic function and vascular postischemic vasodilation associated with microalbuminuria in IDDM patients. Diabetes Care, 1995, 18, 353-60.

Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgraduate Med J. 2001 Jun 1; 77(908):399-402.

Afkhami-Ardekani M, Modarresi M, Amirchaghmaghi E. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol. 2008 Jul; 18(3):112.

Gupta D, Verma L, Khosla P, Dash S. The prevalence of microalbuminuria in diabetes: a study from north India. Diabetes Research and clinical practice. 1991; 12(2):125-8.

Thankappan KR, Shah B, Mathur P, et al. Risk factor profile for chronic non-communicable diseases: results of a community-based study in Kerala, India. Indian J Med Res 2010; 131: 53–63.

N.K Chowta, P.Pant, M.N Chowta microalbuminuria in diabetes mellitus: Association with age, sex, weight and creatinine clearance. Indian journal of Nephrology April 2009/vol 19/issue 2.DOI 10.4103/0971-4065.53322.

Kanakamani J, Ammini AC, Gupta N, and Dwivedi SN. (2010):Prevalence of microalbuminuria among patients with type 2 diabetes mellitus. Diabetes Technology and Therapeutics., 12(2):161-166

Maskari FA, Sadig ME, and Obineche E. (2008):Prevalence and determinants of microalbuminuria among diabetic patients in UAE.BMC Nephrology.,9:1. Available from:http://www.biomedcentral.com/1471- 2369/9/1

American Diabetes Association Medical care in Diabetes 2018 Jan; 37(Supplement 1): S1- S194. https://doi.org/10.2337/dc18-0105).

Acharya K.Regmi S, Sapkota AS, Raut M, and Jha B. (2015): Microalbuminuria status in relation to glycated haemoglobin and duration of type 2 diabetes mellitus.ACCLM, 1(1):21-24.


  • There are currently no refbacks.